within Pharmacolibrary.Drugs.ATC.J;

model J01RA06
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1.0,
    Cl             = 0.15833333333333333,
    adminDuration  = 600,
    adminMass      = 2.0,
    adminCount     = 1,
    Vd             = 0.021,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Cefepime and amikacin is a combination of two antibiotics (cefepime: a fourth-generation cephalosporin and amikacin: an aminoglycoside) used to treat severe bacterial infections, especially in hospital settings for gram-negative bacteria including Pseudomonas species. This combination is commonly employed for empiric or targeted therapy in serious infections, especially in immunocompromised patients. Both drugs are approved and commonly used individually.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for typical adult patients with normal renal function. Actual published PK data for the combined formulation with ATC code J01RA06 (cefepime and amikacin) is not available; parameters are estimated based on individual component data.</p><h4>References</h4><ol><li><p>Baldwin, CM, et al., &amp; Keam, SJ (2008). Meropenem: a review of its use in the treatment of serious bacterial infections. <i>Drugs</i> 68(6) 803–838. DOI:<a href=&quot;https://doi.org/10.2165/00003495-200868060-00006&quot;>10.2165/00003495-200868060-00006</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18416587/&quot;>https://pubmed.ncbi.nlm.nih.gov/18416587</a></p></li><li><p>Barbhaiya, RH, et al., &amp; Pittman, KA (1992). Lack of pharmacokinetic interaction between cefepime and amikacin in humans. <i>Antimicrobial agents and chemotherapy</i> 36(7) 1382–1386. DOI:<a href=&quot;https://doi.org/10.1128/AAC.36.7.1382&quot;>10.1128/AAC.36.7.1382</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1510431/&quot;>https://pubmed.ncbi.nlm.nih.gov/1510431</a></p></li><li><p>Bateman, RM, et al., &amp; Prandi, E (2016). 36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016. <i>Critical care (London, England)</i> 20(Suppl 2) 94–None. DOI:<a href=&quot;https://doi.org/10.1186/s13054-016-1208-6&quot;>10.1186/s13054-016-1208-6</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27885969/&quot;>https://pubmed.ncbi.nlm.nih.gov/27885969</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end J01RA06;
